PDF-Medicare Part B Step Therapy Programs

Page 1 of 10 UnitedHealthcare Medicare Advantage Medical Benefit Injectable Policy Effective 0 7 01 2022 Proprietary Information of UnitedHealthcare Copyright 2022 United HealthCare Se rvic. Overview and Updates for 2014 .      . . Sarah Pitsoulakis. sarah.pitsoulakis@drwi.org. Kate Schilling. kate.schilling@gwaar.org. Pamela . Franke. pjf@legalaction.org. Ginger . Rogers . ginger.rogers@drwi.org. October 14. , 2015. National Coalition on Health Care. Tricia Neuman, Sc. D.. Director, . Program on Medicare . Policy. Kaiser Family Foundation. Actual and Projected Medicare Part B . Premium and Deductible, 2015-2017. Amber Heape, MCD, CCC-SLP, CDP. Clinical Specialist- . PruittHealth. Amber Heape- Disclosures. Relevant Financial Relationships:. Salaried Clinical Specialist for . PruittHealth. Receives honoraria for CE courses and seminars taught, including this one. Medicare Rights Center. The Medicare Rights Center is a national, . nonprofit . consumer service organization that works to ensure access to affordable health care for older adults and people with disabilities through:. April 2018. What We’ll Cover. What are MSPs?. Why are They Important?. Different Types of Coverage. How MSPs Work. Eligibility Rules. Relationship to Other Benefits. How You Can Help Your Clients. Resources. The Medicare Rights Center is a national, nonprofit. consumer service organization that works to . ensure access to affordable health care for older . adults and people with disabilities through. Counseling and advocacy. Module 13. Medicare . and . Other Programs for People With Disabilities. Session Objectives. This session should help you. Recognize eligibility for Social Security programs. Summarize eligibility and enrollment in Medicare . Topics2019 Part C and D Regulation CARA Drug Management Programs 2019 Call Letter Updates Part D Opioid Overutilization GuidanceImpact of Part D Policy Drug Management Programs Part C & D RegulationCo -TherapyDrug subject to Step TherapyTry these Options firstBRAND NAMEGENERIC NAME BRAND NAMEGENERIC or BIOSIMILAR NAME RituxanrituximabTruximarituximab-abbsRiabnirituximab-arrxRuxiencerituximab-pvvrRi Drug subject to Step Therapy BRAND NAME GENERIC NAME Try these Options first BRAND NAME GENERIC or BIOSIMILAR NAME Truxima rituximab-abbs Ruxience rituximab-pvvr Kanjinti trastuzum Medicare costsG E T T I N G S T A R T E DPrograms that can help save you moneyCall to get more informationIt146s important to call your State Medical Assistance Medicaid o31ce or 30ll out an applica Medicare Workshop. Presented by:. www.senior-advisors.com. info@senior-advisors.com. . . - 1Q 2019-. Justin Lubenow. Medicare Specialist. Medicare Advisory Board for National Association of Health Underwriters. Wisconsin SHIP: 1-800-242-1060. Grant Funding Disclaimer. 2. This project was supported by the Wisconsin Department of Health Services with financial assistance, in whole or in part, by grant number 90SAPG0091, from the U.S. Administration for Community Living, Department of Health and Human Services, Washington, D.C. 20201. Grantees undertaking projects with government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not, therefore, necessarily represent official ACL policy.. 2016 Annual Data Report, Vol . 2, ESRD. , . Ch. . 12. 2. a. The . catastrophic coverage amount is the greater of 5% of medication cost or the values shown in the chart above. In 2014, beneficiaries were charged $2.55 for those generic or preferred multisource drugs with a retail price less than $51 and 5% for those with a retail price over $51. For brand name drugs, beneficiaries paid $6.35 for those drugs with a retail price less than $127 and 5% for those with a retail price over $127. Table adapted from http://www.q1medicare.com/PartD-The-2014-Medicare-Part-D-Outlook.php.